Oropharyngeal continuous positive airway pressure: An alternative to intubation for newborns not applied nasal continuous positive airway pressure Sir, Nasal continuous positive airway pressure (CPAP) has been used as a non-invasive form of respiratory assistance to support spontaneously breathing infants with respiratory distress. Nasal CPAP is also effectively used to prevent the failure of extubation in newborn infants following a period of endotracheal intubation and mechanical ventilation. [1] Its use may not be feasible in some newborns with anomalies including nasal aplasia or atresia. In that case, oropharyngeal CPAP, recently defined and used with an increasing trend among neonatologists, can be an alternative technique. [2] A male infant, weighing 2550 g, delivered at the 36 th gestational week, was diagnosed as a case of charge (coloboma of the eye, heart defects, atresia of the nasal choanae, retardation of growth and/or development, genital and/or urinary abnormalities, ear abnormalities and deafness). The patient was transferred to the neonatal Intensive Care Unit for resuscitation and endotracheal intubation.The patient was later operated on the 2 nd post-natal day for bilateral choanal atresia. Both choanae were opened with a probe, and a Nelaton catheter was placed in the nostrils [ Figure 1 ].
He was extubated after 2 days, and oxygen was given by hood-box after extubation using the probes in the nostrils. However, 20 min after extubation, the patient could not tolerate the hood-box process, oxygen saturation fell and he was consequently re-intubated. Optimum settings were activated on mechanic ventilator (peak inspiratory pressure: 12 cmH 2 O, positive end expiratory pressure [PEEP]: 4 cmH 2 O, inspired oxygen concentration [FiO 2 ]: 21% and respiratory rate: 20/min), but respiratory alkalosis developed on the 4 th h of intubation, and the patient was extubated again. Since the patient had no lower respiratory tract problems, the main problem was the airway obstruction leading to oxygen intolerance due to the hood. Therefore, oropharyngeal CPAP was attempted. An endotracheal tube (size 3.5 mm) was placed into the oropharynx by means of a laryngoscope. The tip of the endotracheal tube was fixed advancing to the tip of the back of the tongue with support of fixation straps externally around the patient's lips. Oropharyngeal CPAP was adjusted with the settings of PEEP: 6 cmH 2 O and FiO 2 : 30%. Oxygen saturation improved immediately from 74% to 96%. An orogastric tube was used for the decompression of the distended stomach. On the 5 th day of the treatment, oropharyngeal CPAP was discontinued, and we shifted to head-box oxygen which was successfully tolerated.
CPAP is a non-invasive respiratory assistance technique increasingly being used among neonatologists. Oropharyngeal CPAP technique may be a solution for infants with nasal anomalies such as choanal atresia. We want to highlight this aspect to the anaesthesiologists who frequently encounter patients who cannot tolerate the classic nasal CPAP due to nasal anomalies.
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Anaesthetic induction with fentanyl, thiopentone sodium and rocuronium was uneventful with stable haemodynamics. Arterial blood gas analysis demonstrated normal blood gases and electrolytes. Anaesthesia was maintained with isoflurane, fentanyl and atracurium. In dissection phase, significant blood loss was managed with massive blood transfusion.
Intravenous (IV) fluids with noradrenaline and vasopressin infusion were administered to maintain mean arterial pressure of >65 mm Hg and stroke volume variance of <13. On reperfusion, sudden fall in systemic vascular resistance responded to bolus 200 µg phenylephrine with increased noradrenaline (0.3 µg/kg/min) and vasopressin (2.4 units/h) support. Five hours later, abdominal closure was started with pulse of 60 bpm and blood pressure of 116/74 mm Hg on noradrenaline 0.2 µg/kg/min with vasopressin 1.8 unit/h. Sudden onset ventricular ectopics and bigeminy were observed, which was managed by intermittent 100 mg lignocaine IV and magnesium sulphate 2 g IV infusion. Adequate anaesthetic depth, normal blood gas and electrolytes were confirmed, and sinus rhythm was restored. On resumption of surgical stimulus, recurrent PVT 6-8 beats run at 170-180 bpm were noted with transient response to lignocaine, magnesium sulphate and defibrillation (200 J biphasic shock). Lignocaine infusion was started at 1.5 mg/ kg/h. Loading dose of amiodarone (150 mg) was administered followed by infusion (1 mg/min). Sinus rhythm got restored, but QT interval increased with a corrected QTc of 625 ms. Amiodarone was immediately
